Search for: "Pfizer Inc."
Results 1261 - 1280
of 1,369
Sorted by Relevance
|
Sort by Date
28 Oct 2011, 10:06 am
The Moderator: Ronald Staudt, IIT Chicago-Kent College of Law The Panelists: Toby Brown, Vinson & Elkins; Lisa Damon, Seyfarth Shaw LLP; Paul Lippe, Legal OnRamp; Mark Ohringer, Jones Lang LaSalle Americas, Inc.; and Ellen Rosenthal, Pfizer Lisa Damon, Seyfarth Shaw LLP Seyfarth Lean Background: About 6 years ago, clients started asking for alternative fees. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
19 Aug 2008, 10:35 pm
Vioxx came on the market in June 1999, after rival Pfizer Inc.'s Celebrex. [read post]
16 Nov 2010, 5:45 am
The court relied heavily on Pfizer, Inc. v. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
5 Aug 2010, 11:03 am
The largest Healthcare fraud settlement in U.S. history, against Pfizer Inc., paid six whistleblowers more than $102 million. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
2 Mar 2022, 10:39 am
For example, Holmes’ added the Pfizer logo to company reports, which led large investors, like Walgreens, to believe that the blood tests had been validated by the pharmaceutical giant. [read post]
27 Jan 2014, 9:45 am
” She advocates a carful application of the factors enunciated Pfizer, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
15 Jul 2014, 5:27 am
Jay Martin, Chief Compliance Officer (CCO) at BakerHughes Inc. suggests an approach that reviews key risk factors to move forward. [read post]
30 Oct 2010, 10:00 am
., Pfizer Products, Inc. v. [read post]
4 Sep 2012, 1:21 pm
Pfizer, Inc., 2012 U.S. [read post]
27 Mar 2018, 4:00 am
Pfizer Canada Inc. 2017 FC 826, the Federal Court said that the funding agreement is privileged and refused to order disclosure of the complete unredacted agreement to the defendant. [read post]
7 Apr 2008, 2:56 pm
According to Gregg Engles, former lawyer and current CEO of Dean Foods, Inc., the discrepancy is simple. [4] "Many lawyers let knowledge of risk paralyze them. [read post]
17 Dec 2009, 11:22 am
Pfizer, 562 F.3d 163 (2d Cir. 2009). [read post]
17 Mar 2009, 12:50 pm
This warning procedure was outlined in Est’ee Lauder, Inc. v. [read post]
20 Jun 2023, 5:55 am
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
26 Mar 2012, 1:43 am
Circuit’s 1999 decision in Pfizer Inc. v. [read post]
